Samjo Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78M Sell
24,665
-818
-3% -$158K 2.07% 14
2025
Q4
$4.69M Sell
25,483
-945
-4% -$166K 1.81% 20
2025
Q3
$4.06M Sell
26,428
-725
-3% -$110K 1.55% 20
2025
Q2
$3.79M Sell
27,153
-125
-0.5% -$17.5K 1.6% 19
2025
Q1
$4.01M Sell
27,278
-50
-0.2% -$7.23K 1.7% 21
2024
Q4
$3.58M Sell
27,328
-250
-0.9% -$35K 1.35% 23
2024
Q3
$4.3M Buy
27,578
+8
+0% +$1.29K 1.48% 16
2024
Q2
$4.3M Sell
27,570
-33
-0.1% -$4.97K 1.6% 14
2024
Q1
$3.74M Buy
27,603
+2,138
+8% +$283K 1.32% 14
2023
Q4
$3.43M Buy
+25,465
New +$3.31M 1.21% 15

Other funds holding AZN

Samjo Management's AZN Position: Q1 2026 in Review

Samjo Management reduced its AstraZeneca (AZN) stake by 3.2% in Q1 2026, selling an estimated $158K and leaving 24,665 shares worth $4.78M. The position accounts for 2.07% of the portfolio, ranked #14.

Samjo Management first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Samjo Management held 24,665 shares of AstraZeneca worth $4.78M as of Q1 2026.
  • Samjo Management sold 818 AstraZeneca shares in Q1 2026, an estimated $158K.
  • AstraZeneca made up 2.07% of Samjo Management's portfolio in Q1 2026, its #14 holding.
  • Samjo Management first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Samjo Management's 13F filing for Q1 2026, filed 15 May 2026.